Page 2 - Generics Lobby News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This restricts access, because some of these drugs just cost too much to people. on the flip side of that, the the argument, though, that without the ability to make a big profit on these drugs, that drug companies would have less of a motivation to research and develop, to develop new life-saving drugs. >> reporter: that is precisely what the argument that jim greenwood and pharma makes. that is the argument that they made going door to door here on capitol hill and it is the argument that prevailed. the other side, the generics lobby, and the people who were involved in that and support that...

In the democratic party. >> reporter: to be sure, the generics lobby did have powerful allies. not just the president but aarp, unions, and more. but brand name biologics outspent them and worked the system. jim greenwood isn't just the president of bio, he's a former member of congress. you're a former member of the club? >> right. >> reporter: that helps? >> well, it helps in this way. it helps -- i know what people want -- what they need, what kind of information they need before they vote. >> reporter: the result in this committee and others, many democrats voted to give brand name biologi...